VRN 📈 Veren - Overview
Exchange: NYSE • Country: Canada • Currency: USD • Type: Common Stock • ISIN: CA22576C1014
VRN: Crude Oil, Natural Gas, Natural Gas Liquids
Veren Inc. explores, develops, and produces oil and gas properties in Canada and the United States. The company focuses on crude oil, tight oil, natural gas liquids, shale gas, and natural gas reserves. Its properties are located in the provinces of Saskatchewan, Alberta, British Columbia, and Manitoba; and the states of North Dakota. The company was formerly known as Crescent Point Energy Corp. and changed its name to Veren Inc. in May 2024. Veren Inc. was incorporated in 1994 and is headquartered in Calgary, Canada. Web URL: https://www.vrn.com
Additional Sources for VRN Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
VRN Stock Overview
| Market Cap in USD | 2,877m |
| Sector | Energy |
| Industry | Oil & Gas E&P |
| GiC Sub-Industry | Oil & Gas Exploration & Production |
| IPO / Inception | 2006-07-20 |
VRN Stock Ratings
| Growth 5y | 26.1% |
| Fundamental | 50.2% |
| Dividend | 81.1% |
| Rel. Strength Industry | -15802 |
| Analysts | 4.5/5 |
| Fair Price Momentum | 4.07 USD |
| Fair Price DCF | 29.74 USD |
VRN Dividends
| Dividend Yield 12m | 7.22% |
| Yield on Cost 5y | 9.09% |
| Annual Growth 5y | 55.10% |
| Payout Consistency | 80.5% |
VRN Growth Ratios
| Growth Correlation 3m | -89.6% |
| Growth Correlation 12m | -45.6% |
| Growth Correlation 5y | 81.1% |
| CAGR 5y | 4.70% |
| CAGR/Mean DD 5y | 0.15 |
| Sharpe Ratio 12m | -0.99 |
| Alpha | -59.35 |
| Beta | 1.15 |
| Volatility | 40.16% |
| Current Volume | 13929.4k |
| Average Volume 20d | 7984.7k |
What is the price of VRN stocks?
As of December 22, 2024, the stock is trading at USD 4.66 with a total of 13,929,400 shares traded.
Over the past week, the price has changed by -9.53%, over one month by -14.01%, over three months by -30.33% and over the past year by -32.69%.
As of December 22, 2024, the stock is trading at USD 4.66 with a total of 13,929,400 shares traded.
Over the past week, the price has changed by -9.53%, over one month by -14.01%, over three months by -30.33% and over the past year by -32.69%.
Is Veren a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Veren (NYSE:VRN) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 50.23 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of VRN as of December 2024 is 4.07. This means that VRN is currently overvalued and has a potential downside of -12.66%.
Partly, yes. Based on ValueRay Fundamental Analyses, Veren (NYSE:VRN) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 50.23 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of VRN as of December 2024 is 4.07. This means that VRN is currently overvalued and has a potential downside of -12.66%.
Is VRN a buy, sell or hold?
Veren has received a consensus analysts rating of 4.50. Therefor, it is recommend to buy VRN.
Veren has received a consensus analysts rating of 4.50. Therefor, it is recommend to buy VRN.
- Strong Buy: 8
- Buy: 5
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecast for VRN stock price target?
According to ValueRays Forecast Model, VRN Veren will be worth about 4.4 in December 2025. The stock is currently trading at 4.66. This means that the stock has a potential downside of -5.58%.
According to ValueRays Forecast Model, VRN Veren will be worth about 4.4 in December 2025. The stock is currently trading at 4.66. This means that the stock has a potential downside of -5.58%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 7.4 | 58.2% |
| Analysts Target Price | 10.7 | 130.3% |
| ValueRay Target Price | 4.4 | -5.6% |